Fintel · Aug 28, 2026
NU
NYSE · NUS
Nu Skin Enterprises, Inc.
Consumer Defensive · Household & Personal Products
$4.84
Down-$0.09 (-1.86%)
Updated Sep 9, 2026, 1:13 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 518.35M
- P/E ratio
- 4.71
- Dividend yield
- 4.96%
- 52-week range
- $4.49 – $8.08
- Volume
- 390.45K
- Avg. volume
- 507.91K
Price performance
NUS price history
1M range · 19 trading sessions · Daily adjusted prices
NUS closed at $4.84 after 19 trading sessions, down 0.62% for the selected period.
- Last close
- $4.84
- Period change
- -0.62%
- Period low
- $4.57
- Period high
- $4.87
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $4.69 | $4.87 | $4.67 | $4.84 | 390.45K |
| Sep 3, 2026 | $4.89 | $4.925 | $4.628 | $4.70 | 502.86K |
| Sep 2, 2026 | $4.59 | $4.945 | $4.59 | $4.83 | 710.89K |
| Sep 1, 2026 | $4.70 | $4.77 | $4.55 | $4.57 | 685.91K |
| Aug 31, 2026 | $4.85 | $4.85 | $4.62 | $4.69 | 842.64K |
| Aug 28, 2026 | $4.81 | $4.93 | $4.765 | $4.85 | 360.25K |
| Aug 27, 2026 | $4.79 | $4.86 | $4.75 | $4.79 | 356.09K |
| Aug 26, 2026 | $4.88 | $4.915 | $4.81 | $4.84 | 409.04K |
| Aug 25, 2026 | $4.74 | $4.87 | $4.68 | $4.85 | 297.97K |
| Aug 24, 2026 | $4.74 | $4.83 | $4.73 | $4.77 | 433.49K |
| Aug 21, 2026 | $4.69 | $4.76 | $4.67 | $4.74 | 318.93K |
| Aug 20, 2026 | $4.76 | $4.775 | $4.525 | $4.65 | 546.01K |
| Aug 19, 2026 | $4.76 | $4.955 | $4.70 | $4.79 | 542.9K |
| Aug 18, 2026 | $4.67 | $4.745 | $4.62 | $4.70 | 601.25K |
| Aug 17, 2026 | $4.77 | $4.78 | $4.61 | $4.68 | 606.54K |
| Aug 14, 2026 | $4.87 | $4.93 | $4.79 | $4.80 | 493.89K |
| Aug 13, 2026 | $4.91 | $4.96 | $4.70 | $4.85 | 612.93K |
| Aug 12, 2026 | $4.82 | $5.165 | $4.82 | $4.85 | 655.37K |
| Aug 11, 2026 | $4.60 | $4.98 | $4.49 | $4.87 | 1.77M |
Latest NUS news
The latest Smart Investors Daily articles mentioning NUS.
Stock researchCompany · Overview
NUS research
Overview
Company profile and research snapshot.
Company profile
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $11.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Dec 20, 2024 | DA Davidson | Neutral | — |
| Oct 22, 2024 | Citigroup | Neutral | — |
| Aug 12, 2024 | DA Davidson | Neutral | — |
| Aug 9, 2024 | Citigroup | Neutral | — |
| May 9, 2024 | DA Davidson | Neutral | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 11, 2026
Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript
Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call August 10, 2026 5:00 PM EDTCompany ParticipantsB.G.
SeekingAlpha · Aug 10, 2026
Nu Skin Enterprises, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-10. The following slide deck was published by Nu Skin Enterprises, Inc.
Benzinga · Aug 10, 2026
Nu Skin Enterprises Sees FY2026 GAAP EPS $(4.90)-$(4.73)
Nu Skin Enterprises (NYSE:NUS) is looking for FY2026 GAAP EPS of $(4.90)-$(4.73)..
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
